Humanized anti-CCR2 Antibody for the Therapy of MS and RA
Scientists of the University of Göttingen and of the University of Regensburg developed in collaboration a proprietary anti-CCR2 antibodies for the therapy of Multiple Sclerosis (MS) and potentially Rheumatoid Arthritis (RA).The lead candidate Doc-2 has been humanized in collaboration with the MRC Technologies. It targets the CCR2 receptor and modulates the autoimmune process through depletion of CCR2+ monocytes.
Further information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
“Segment-jumping” ridgecrest earthquakes explored
Seismologists use supercomputer to reveal complex dynamics of multi-fault earthquake systems. On the morning of July 4, 2019, a magnitude 6.4 earthquake struck the Searles Valley in California’s Mojave Desert,…
“Sustainable” condenser tumble dryers
… create hundreds of tonnes of waterborne microfiber pollution. A new study has revealed that drying laundry using a condenser tumble dryer leads to hundreds of tonnes of potentially harmful…
Not so biodegradable
New study finds bio-based plastic and plastic-blend textiles do not biodegrade in the ocean. First-of-its-kind experiment off Scripps Pier finds only natural fibers degrade in the marine environment; plastic fabrics…

















